Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10716756 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL10821138 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL3172765 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL10582668 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL2567832 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL7717417 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL7065108 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL11159859 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL769596 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG | |
| SCHEMBL9290892 | 1.00 | TRPA1 (0.59) | TRPA1CES2CES1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111773130-A | Hydroxypropyl tetrahydropyrane triol compound and preparation method and application thereof | 贝乐科(上海)生物科技有限公司 | 2020-10-16 | — | — | CN | claimed |
| WO-1996006102-A1 | PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDE MIXTURES | CIBA-GEIGY AG (CH) | 1996-02-29 | — | — | WO | claimed |
| CN-119367549-A | Hydrophilic linkers and conjugates thereof | 芬兰吉利科斯有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-111065416-B | Hydrophilic linkers and conjugates thereof | 芬兰吉利科斯有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118147152-A | Aptamer for detecting Neu5Gc and method for detecting Neu5Gc based on AP-Cas12a | 吉林大学 | 2024-06-07 | — | — | CN | disclosed |
| US-20230321259-A1 | GLYCOCONJUGATES AND MEDICAL USES THEREOF | REMAB THERAPEUTICS SL (ES) | 2023-10-12 | — | — | US | disclosed |
| CN-116437966-A | Glycoconjugates and medical uses thereof | 瑞马布治疗有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-113748212-B | Enzymatic process for preparing GDP-fucose | 马克斯·普朗克科学促进学会 | 2023-04-25 | — | — | CN | disclosed |
| CN-115944643-A | Application of sialic acid in preparing anti-osteoporosis medicine and food | 江南大学附属医院 | 2023-04-11 | — | — | CN | disclosed |
| CN-114641577-A | Enzymatic process for the preparation of UDP-galactose | 马克斯·普朗克科学促进学会 | 2022-06-17 | — | — | CN | disclosed |
| CN-114630911-A | Enzymatic process for the preparation of UDP-GlcNAc | 马克斯·普朗克科学促进学会 | 2022-06-14 | — | — | CN | disclosed |
| WO-1998047915-A1 | NEOGLYCOPROTEINS | NOVARTIS AG (CH) | 1998-10-29 | — | — | WO | disclosed |
| EP-0866802-A1 | MULTIVALENT POLYMERS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE FOR PREPARING BIOLOGICALLY ACTIVE COMPOUNDS. | Novartis AG (CH) | 1998-09-30 | — | — | EP | disclosed |
| EP-0801684-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | Novartis AG (CH) | 1997-10-22 | — | — | EP | disclosed |
| WO-1997019105-A1 | MULTIVALENT POLYMERS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE FOR PREPARING BIOLOGICALLY ACTIVE COMPOUNDS. | NOVARTIS AG (CH) | 1997-05-29 | — | — | WO | disclosed |
| US-5610016-A | REACTING A GLYOXAL DERIVATIVE, CHEMILUMINESCENCE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-11 | — | — | US | disclosed |
| US-5569786-A | ANTICARCINOGENIC AGENTS, LEUKEMIA | ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1996-10-29 | — | — | US | disclosed |
| WO-1996024683-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | NOVARTIS AG (CH) | 1996-08-15 | — | — | WO | disclosed |
| WO-1996006102-A1 | PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDE MIXTURES | CIBA-GEIGY AG (CH) | 1996-02-29 | — | — | WO | disclosed |
| EP-0675360-A2 | Method for measuring adenyl group containing substances using heteropoly acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1995-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321259-A1 | GLYCOCONJUGATES AND MEDICAL USES THEREOF | B3GAT3, FUT5, FUT6 | TRPA1 4573/4885CES2 1111/4885CES1 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.